Barclays lowered the firm’s price target on Travelers (TRV) to $280 from $287 and keeps an Overweight rating on the shares as part of a Q1 earnings preview for the insurance group. With life earnings facing challenges Barclays favors group benefits, excess capital, and “cheap” cash flows, the analyst tells investors in a research note. The firm says the sector is “navigating uncertainty.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TRV:
- Travelers price target lowered to $245 from $250 at Morgan Stanley
- Apple, Starbucks upgraded: Wall Street’s top analyst calls
- Travelers price target lowered to $267 from $270 at UBS
- Travelers upgraded to Equal Weight from Underweight at Wells Fargo
- Travelers price target lowered to $274 from $286 at Keefe Bruyette
